C1QBP and cardiac arrhythmia: In our study, its antiarrhythmic effect seems to be specific to TANGO2-deficient cells; however, it may have broader implications in other arrhythmias associated with genes commonly implicated in energy or metabolic processes, such as TECRL (38), EXOSC5 (39), and C1QBP (40).